PROTACs and Molecular Glues: How Targeted Protein Degradation Is Redefining Drug DiscoveryNeuroinflammation As A Target Class: The New Frontier In CNS Drug DevelopmentSenolytics and Microbiome Modifiers Two Quiet Levers Reshaping the Biology of Ageing
Beyond CSR- ESG Moves Into Boardrooms
- Cover Story: ESG in Pharma.
- In Talks with Leadership: Featuring Mr. Abhay Kumar Srivastava
- Market Insights: Packaging transformation & AI-led drug repurposing.
- Startup & Innovation: How GenepoweRx is transforming the genomic landscape.
- Manufacturing: Biocatalysis, automation, digital labs, and smart pharma operations.
























